2025-07-16 - Analysis Report
Okay, here's an analysis of Merck & Co Inc (MRK) based on the provided data, formatted in English with numbers and a brief analysis, as requested.

**Report: Merck & Co Inc (MRK) Analysis**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** MRK
*   **Company:** Merck & Co Inc. (A global pharmaceutical company focused on developing medicines and vaccines.)
*   **MRK Cumulative Return:** -2.25%
*   **VOO (S&P 500) Cumulative Return:** 95.00%
*   **Relative Divergence:**
    *   Max: 23.1
    *   Min: -99.5
    *   Current: -95.5
    *   Relative Position: 3.3

**Analysis:** MRK has significantly underperformed the S&P 500 (VOO) over the analyzed period.  The current relative divergence is near its historical low, indicating a substantial performance gap. The relative position of 3.3 suggests MRK's underperformance is near the most extreme level observed in the provided data.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha    | Beta   | Cap(B) |
| ---------- | ------- | ----- | -------- | ------ | ------ |
| 2015-2017  | 5.0%    | 58.2% | -24.0%   | -0.0   | 134.8  |
| 2016-2018  | 43.0%   | 66.4% | 25.0%    | -0.1   | 183.1  |
| 2017-2019  | 40.0%   | 66.4% | 11.0%    | 0.3    | 217.9  |
| 2018-2020  | 20.0%   | 66.4% | 0.0%     | 0.3    | 196.0  |
| 2019-2021  | -1.0%   | 65.6% | -50.0%   | 0.3    | 192.4  |
| 2020-2022  | 13.0%   | 69.5% | 11.0%    | 0.3    | 278.6  |
| 2021-2023  | 31.0%   | 69.5% | 13.0%    | 0.3    | 273.8  |
| 2022-2024  | -7.0%   | 69.5% | -33.0%   | 0.2    | 249.8  |
| 2023-2025  | -54.0%  | 61.4% | -101.0%  | 0.5    | 204.7  |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate has fluctuated significantly, with recent periods showing negative growth.
*   **MDD:** Maximum Drawdown is consistently high, indicating substantial risk.
*   **Alpha:** Alpha is frequently negative, showing underperformance relative to the benchmark.  The most recent period has a very negative Alpha.
*   **Beta:** Beta values are generally low, suggesting MRK has not been strongly correlated with the overall market.
*   **Cap(B):** Market capitalization has fluctuated over time.

**2. Recent Stock Price Movements**

*   **Closing Price:** 81.52
*   **Last Market Data:**
    *   Price: 81.52
    *   Previous Close: 83.67
    *   Change: -2.57
*   **5-Day Moving Average:** 83.26
*   **20-Day Moving Average:** 80.90
*   **60-Day Moving Average:** 79.62

**Analysis:** The stock price closed lower than the previous day and is currently below its 5-day moving average, suggesting recent downward momentum.  The price is above the 20-day and 60-day moving averages.

**3. Technical Indicators and Expected Return**

*   **MRI (Market Risk Indicator):** 0.34 (Low Risk)
*   **RSI (Relative Strength Index):** 55.09
*   **PPO (Percentage Price Oscillator):** 0.24
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence (20-day):** 3.0 (+), which means short-term increase
*   **Expected Return:** -317.1%

**Analysis:**

*   The MRI indicates "Low Risk" market conditions.
*   The RSI is neutral (around 50), not indicating overbought or oversold conditions.
*   The PPO is slightly positive.
*   The Hybrid Signal suggests a cautious buy signal.
*   The negative Expected Return is very concerning and suggests significant potential underperformance compared to the S&P 500 over the long term.
*   The recent price change is negative.

**4. Recent News & Significant Events**

*   **[2025-07-15]** Major business developments, regulatory changes, or market events.
*   **[2025-07-12]** Analyst discussions about recent performance and outlook.
*   **[2025-07-13]** Stock volatility influenced by recent news.
*   **[2025-07-14]** Market experts highlighting risks and opportunities.

**Analysis:** Recent news indicates potential volatility and significant events impacting MRK. Investors should carefully monitor news and company announcements.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
| ---------- | ---- | ------------ |
| 2025-05-02 | 2.01 | 15.53 B$     |
| 2024-11-06 | 1.25 | 16.66 B$     |
| 2024-08-05 | 2.15 | 16.11 B$     |
| 2024-05-03 | 1.88 | 15.78 B$     |
| 2025-05-02 | 1.88 | 15.78 B$     |

**Analysis:** Revenue and EPS have fluctuated over the past year. The most recent EPS number is positive.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue     | Profit Margin |
| ---------- | ----------- | ------------- |
| 2025-03-31 | \$15.53B    | 77.98%        |
| 2024-12-31 | \$15.62B    | 75.50%        |
| 2024-09-30 | \$16.66B    | 75.51%        |
| 2024-06-30 | \$16.11B    | 76.76%        |
| 2024-03-31 | \$15.78B    | 77.56%        |

**Capital and Profitability**

| Quarter    | Equity      | ROE      |
| ---------- | ----------- | -------- |
| 2025-03-31 | \$48.34B    | 10.51%   |
| 2024-12-31 | \$46.31B    | 8.08%    |
| 2024-09-30 | \$44.50B    | 7.09%    |
| 2024-06-30 | \$43.58B    | 12.52%   |
| 2024-03-31 | \$40.36B    | 11.80%   |

**Analysis:** Revenue has shown some variability, with a recent slight decrease. Profit margins remain strong. Equity has generally increased over the observed period, and ROE fluctuates.

**7. Overall Analysis**

MRK has significantly underperformed the S&P 500 recently, with a very negative expected return.  While financial metrics like profit margins and ROE are generally positive, recent price action, negative alpha, and news suggesting volatility should raise caution. The hybrid signal advises a cautious buy, but the very low expected return should be carefully considered. Recent news events seem to be driving volatility.  The substantial negative divergence from the S&P 500, combined with a concerningly low long-term expected return, suggests significant risks associated with investing in MRK at this time. Investors should carefully review all available information and assess their risk tolerance before making any decisions.
